FDA Cannot Remain MIA As States', Cities' Drug-Litigation Crusade ...

https://www.forbes.com/.../fda-cannot-remain-mia-as-states-cities-drug-litigation-crusa...

6 hours ago - The Food & Drug Administration should continue its third-party courtroom advocacy for national regulatory uniformity by urging courts to dismiss state-law claims against pain medication manufacturers whose results could conflict with federal law.